Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Frontiers in Medicine|July 23, 2020
Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting AgentsLeanna M Wise, William StohlNature Biotechnology|January 11, 2012
The discovery and development of belimumab: the anti-BLyS-lupus connectionWilliam Stohl, David M HilbertAmerican Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 18, 2022
Maternal and cord blood BAFF and APRIL levels during pregnancyHindi E Stohl, William StohlACR Open Rheumatology|August 14, 2024
T cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical OutcomesWilliam Stohl, Ying Wu, Malka StohlImmunohorizons|July 25, 2022
Preferential Expansion of Foxp3+ T Regulatory Cells in CTLA-4-Deficient and CTLA-4-Haploinsufficient C57BL/6 MiceWilliam Stohl, Ning Yu, Ying WuImmunology|August 31, 2024
Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 miceWilliam Stohl, Ying Wu, Malka StohlJournal of Immunology (Baltimore, Md. : 1950)|November 25, 2022
B Cell and T Cell Dissimilarities in BAFF-Deficient versus BR3-Deficient C57BL/6 MiceWilliam Stohl, Ning Yu, Ying WuClinical Immunology (Orlando, Fla.)|September 23, 2003
In vitro and in vivo T cell oligoclonality following chronic stimulation with staphylococcal superantigensKyoung Soo Kim, Noam Jacob, William StohlAmerican Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 10, 2021
First-trimester serum BAFF:sFlt-1 ratio as a candidate early biomarker of spontaneous abortionHindi E Stohl, Ning Yu, William StohlExpert Opinion on Biological Therapy|January 30, 2026
New biological agents in systemic lupus erythematosusMartha Delgado, Leanne M Wise, William StohlPageof 12